electroCore price target raised to $25 from $22 at H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on electroCore (ECOR) to $25 from $22 and keeps a Buy rating on the shares after the company entered into a definitive merger agreement to acquire NeuroMetrix. The acquisition appears to be to the benefit of electroCore, without expected material dilution of the company’s cash or equity, the analyst tells investors in a research note. The firm says Quell expands its non-invasive pain therapy portfolio.